TickerFactsScreenerDevelopers

Acrivon Therapeutics, Inc. (ACRV) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2020: -$8.41M2021: -$23.81M2022: $170.47M2023: $121.19M2024: $176.79M2025: $112.52M$112.52M
2020Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$112.52M-36.4%
2024$176.79M+45.9%
2023$121.19M-28.9%
2022$170.47M+816.0%
2021-$23.81M-183.0%
2020-$8.41M—